Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Another Change At Perrigo Helm As Results Remain Turbulent

Oct 09 2018

• By Malcolm Spicer

Related Content

Rulemaking For OTC Switch Process Changes Pushed To 2019

Jun 12 2018

Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent

Oct 03 2018

Perrigo's OTC Core Could Expand To Include National Brands

Aug 10 2018

Amazon OTCs Likely A Worry For Retailers, A Remedy For Perrigo

Jan 03 2018

Perrigo Taps CEO With Global Operations Expertise At Pharma Packaging Firm

Jan 09 2018

Perrigo CEO Takes Faith In Rx Generics Business To Exit Door With Him

Jun 06 2017

Perrigo Trims Workforce, Ships Tysabri License, Stays European Course

Mar 01 2017

Deal Watch: WuXi/Gloria License PD-1 Inhibitor To Arcus For Up To $816m

Aug 18 2017

Related Companies

Perrigo Company PLC

Bausch Health Companies Inc.

Viatris Inc.

Royalty Pharma plc

Merck & Co., Inc.

Johnson & Johnson

Additional Topics

Executive Changes Prescription To OTC Switch Advertising, Marketing & Sales Business Strategies Deals Generic Drugs OTC Drugs BioPharmaceutical Consumer

More from Leadership

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window